Dr. Xiaowen Wang, MD

Dr. Wang practices at Optum - Founders in Everett, Washington.

Dr. Wang's NPI, 1548371180, was assigned on August 31, 2006. Dr. Wang holds Washington license MD00044828.

Dr. Wang's primary practice is Optum - Founders, at 3901 Hoyt Avenue, Everett, WA 98201. The practice phone is (425) 317-3400.

Dr. Wang's primary practice is Optum - Founders in Everett, Washington. Dr. Wang is also affiliated with Providence Regional Medical Center Everett. The medical group on file is The Everett Clinic. Dmand AI also links Dr. Wang to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Wang's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Wang is licensed in Washington.

CMS data shows 19,721 Medicare services from Dr. Wang across 37 procedure codes in 2024, for 498 Medicare patients. Medicare paid $487,812 for them.

CMS counts 498 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 216 patients. 71% of them have high blood pressure, and 64% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 73, with 69% women.

In 2024, Dr. Wang wrote 1,457 Medicare Part D claims for 363 patients. 81% of them were for generic drugs. CMS names the drug for 1,160 of them, across 30 drugs with 11 or more claims each, at $3,367,029 in total drug cost. In 2023, CMS named 853 claims across 24 drugs.

Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

Dmand AI links 23 papers to Dr. Wang, published from 2011 to 2025. 2015 was the busiest year, with 4. The most frequent topics are Mitochondrial Proteins, Saccharomyces cerevisiae and Saccharomyces cerevisiae Proteins. Dr. Wang has published most often in Mol Biol Cell. Dr. Wang's most frequent co-authors are Christopher J. Barden, MD, Steven Kenneth Libutti and Henry Lin, MD.

CMS Open Payments shows 73 general payments to Dr. Wang from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Seagen Inc. paid the most, $9,406.